Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10959)
  2. Meeting Abstract (9510)
  3. Review (567)
  4. Book Section (417)
  5. Editorial (337)
  6. Guidelines (159)
  7. Correspondence (119)
  8. Conference Paper (107)
  9. Research Letter (62)
  10. Miscellaneous (55)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22295)
  2. GSK Faculty (5936)
  3. Genitourinary Oncology Service (5660)
  4. Survivorship Research (5240)
  5. Gastrointestinal Oncology Service (4708)
  6. Breast Medicine Service (4165)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1131)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (872)
  6. Eileen O'Reilly (795)

More People

Years
  1. 2025 (695)
  2. 2024 (1389)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5297)
  2. Annals of Oncology (1297)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (779)
  5. Journal of Thoracic Oncology (534)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5590)
  2. Elsevier Inc. (2674)
  3. American Association for Cancer Research (2330)
  4. Oxford University Press (1821)
  5. Nature Publishing Group (1044)
  6. Springer (983)

More Publishers

Results (22319)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Can ultra-hypofractionated stereotactic radiation after radical prostatectomy cut time on treatment or are the data not sharp enough?
    Editorial

    McBride, S. M.; Scher, H. I.
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant PD-1 and PD-L1 blockade with chemotherapy for borderline resectable and unresectable Stage III non-small cell lung cancer
    Journal Article

    Ricciuti, B.; Fusco, F.; Cooper, A.; Garbo, E.; Pecci, F.; Aldea, M.; Wang, X.; Mayoral Penalva, M.; Ginsberg, M.; Sholl, L. M.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Repurposing Food and Drug Administration-approved cancer therapies: Exploring endocrine and targeted pathways in low-grade serous ovarian cancer treatment
    Review

    Podder, V.; Grisham, R. N.; Coleman, R. L.; Cobb, L. P.; Monk, B. J.; Herzog, T. J.; Gershenson, D. M.; Slomovitz, B. M.
    International Journal of Gynecological Cancer (2025)

    Fulltext@MSK | Save
  • Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer
    Journal Article

    Rousseau, B.; Patel, M.; Artz, O.; Vlachos, G.; Patel, S.; Hayatt, O.; Argilés, G.; Foote, M. B.; Luo, L.; Shah, R.; more...
    Cancer Cell (2025)

    Fulltext@MSK | Save
  • The Dublin International Society of Urological Pathology (ISUP) consensus conference on best practice recommendations on the pathology of urachal neoplasms
    Guidelines

    Reis, H.; Al-Ahmadie, H.; Gaisa, N. T.; Lopez-Beltran, A.; Maclean, F.; Tsuzuki, T.; Werneck da Cunha, I.; Amin, M. B.; Aning, J.; Aron, M.; more...
    American Journal of Surgical Pathology (2025)

    Fulltext@MSK | Save
  • Health-related quality of life, pain, and symptomatic skeletal events with [(177)Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): An open-label, randomised, phase 3 trial
    Journal Article

    Fizazi, K.; Morris, M. J.; Shore, N.; Chi, K. N.; Crosby, M.; de Bono, J. S.; Herrmann, K.; Roubaud, G.; Nagarajah, J.; Fleming, M.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: Primary results of a multicentre, single-arm, phase 2 study
    Journal Article

    Elimova, E.; Ajani, J.; Burris, H.; Denlinger, C. S.; Iqbal, S.; Kang, Y. K.; Kim, J. H.; Lee, K. W.; Lin, B.; Mehta, R.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab and chemotherapy versus chemotherapy in advanced metastatic gastroesophageal adenocarcinoma: The phase III, randomized LEAP-015 study
    Journal Article

    Shitara, K.; Lorenzen, S.; Li, J.; Bai, Y. X.; Fernández, M. G.; Aguilar, M.; Shoji, H.; Reyes-Cosmelli, F.; Peña, Y. R.; Corrales, L.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Zipalertinib in patients with epidermal growth factor receptor exon 20 insertion-positive non-small cell lung cancer previously treated with platinum-based chemotherapy with or without amivantamab
    Journal Article

    Piotrowska, Z.; Passaro, A.; Nguyen, D.; Ruiter, G.; Soo, R. A.; Lee, V. H. F.; Velcheti, V.; Tan, D. S. W.; Lee, S. H.; Kim, S. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Use of low-value cancer treatments in Medicare Advantage versus traditional Medicare
    Journal Article

    Jung, J.; Carlin, C.; Feldman, R.; Song, G.; Mitchell, A.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save